University of South Florida
SARS-CoV-2 Neurotropism: Understanding Effects at the Blood-Brain Barrier and Hematogenous Neuroinvasiveness
Abstract
dc:descriptionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19, has provisional counts of over 110 million documented cases and 1.218 million deaths (as of February 2024) in the United States since January 2020. SARS-CoV-2 is an airborne respiratory virus that primarily infects the lungs via the ACE2 receptor but has well-documented secondary target organs including the kidneys, the gastrointestinal tract, the heart, and the skin. SARS-CoV-2 also infects the brain, but the hematogenous route of viral entry to brain is still not fully characterized. Understanding how SARS-CoV-2 traverses the blood-brain barrier (BBB) as well as how it affects the molecular functions of the BBB are unclear. In this study, we investigated the roles of the receptors angiotensin converting enzyme 2 (ACE2) and dipeptidyl peptidase 4 (DPP4) in SARS-CoV-2 infection of the discrete cellular components of a transwell BBB model comprising HUVECs, astrocytes, pericytes. Our results demonstrate that direct infection on the BBB model does not modulate paracellular permeability. Also, our results show that SARS-CoV-2 utilizes clathrin and caveolin-mediated endocytosis to traverse the BBB resulting in direct infection of the brain-side of the BBB model with minimal endothelial infection. In conclusion, the BBB is susceptible to SARS-CoV-2 infection in multiple ways including direct infection of endothelium, astrocytes, and pericytes involving ACE2 and/or DPP4 and the blood-to-brain transcytosis, which is a stochastic event that does not require the presence of host receptors.Up to 30% of individuals with mild to severe disease develop long COVID, exhibiting diverse neurologic symptoms including dementias. However, there is a paucity of knowledge of molecular brain markers and whether these can precipitate the onset of Alzheimer’s disease (AD). Herein, we report the brain gene expression profiles of severe COVID-19 patients showing increased expression of innate immune response genes and genes implicated in AD pathogenesis. The use of a mouse-adapted strain of SARS-CoV-2 (MA10) in an aged mouse model shows evidence of viral neurotropism, prolonged viral infection, increased expression of p-tau particularly in the brain parenchyma adjacent to CD31+ staining. Brain histopathology shows AD signatures including increased tau-phosphorylation, tau-oligomerization in aged MA10 infected mice. The results of gene expression profiling of SARS-CoV-2-infected and AD brains and studies in the MA10 aged mouse model taken together provide evidence suggesting that SARS-CoV-2 infection alters expression of genes in the brain associated with the development of AD.
Degree
thesis:*- Name thesis:degree_name
- Doctor of Philosophy (Ph.D.)
- Level thesis:degree_level
- Dissertation
- Discipline thesis:degree_discipline
- Medicine
- Grantor
- University of South Florida
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Martinez, Taylor E.
- Contributors dc:contributor
-
- Subhra Mohapatra, Ph.D.
- Paula Bickford, Ph.D.
- Alison Willing, Ph.D.
- Jerome Breslin, Ph.D.
- Andreas Seyfang, Ph.D.
Subjects
dc:subject × 7Identifiers
dc:identifier.*- Repository record dc:identifier
- https://digitalcommons.usf.edu/etd/10531